Cantor Fitzgerald, L. P.
- SEC CIK
- 0001024896
- Latest filing
- Aug 19, 2026
CERO holding history
Cero Therapeutics Holdings, Inc. in every 13F filed by Cantor Fitzgerald, L. P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERO overviewAll 13F holders of CEROFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −155,000−100.0% | Sold out | Holders |
| Q4 2024 | 155,000 | $10.0K | <0.1% | +155,000 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −155,000−100.0% | Sold out | Holders |
| Q4 2023 | 155,000 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 155,000 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 155,000 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 155,000 | $2 | <0.1% | +155,000 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −750,000−100.0% | Sold out | Holders |
| Q2 2022 | 750,000 | $7.51M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 750,000 | $7.50M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2021 | 750,000 | $7.43M | 0.5% | – | No prior filing | Holders |